glp 1 8 in Americans is now taking a GLP-1 medication. Yet for many patients, the conversation still begins and ends with weight loss. The future of GLP-1 therapy lies in comprehensive protocols 1 in 8 Americans is

A natural drink mix that supports appetite control, metabolic balance, and digestive wellness through clinically backed plant compounds

Our deep and diverse obesity clinical pipeline is built to attempt to address critical gaps in care and meet patients where they are with optionality

Get expert medical advice at no cost before you begin

The result? Less sugar cravings and crashesjust balanced, sustained energy throughout the day

Clinically Backed Probiotic Always Alive: This advanced probiotic arrives alive and activates within hours in your small intestine where 90% of nutrient absorption occurs, fostering balanced gut health and supporting regularity for optimal daily comfort

Optimized Patient Experience: Featuring audible feedback during dose adjustment and a low injection resistance of less than 30N, the BH0037-IR minimizes user effort and enhances dose confidence